Generic placeholder image

Current Topics in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1568-0266
ISSN (Online): 1873-4294

Review Article

Novel Multitarget Hybrid Compounds for the Treatment of Alzheimer’s Disease

Author(s): Patrycja Michalska, Izaskun Buendia, Laura del Barrio and Rafael Leon

Volume 17 , Issue 9 , 2017

Page: [1027 - 1043] Pages: 17

DOI: 10.2174/1568026616666160927154116

Price: $65

Abstract

Alzheimer’s disease (AD) is the most prevalent among the aging diseases known as neurodegenerative disorders. Drug design programs over the last two decades were mainly based on the cholinergic, the amyloid or the tau hypothesis. However, none of the new drugs have a real impact on the outcome of the disease. The complex nature of AD has led to new approaches for drug development programs, the multitarget drug design hypothesis. Based on this hypothesis, the generation of multitarget hybrid compounds from previously known active molecules has been one of the most widely used to obtain new candidates for the future treatment of AD. Here, we summarize recent developments based on the hybridization hypothesis to obtain a potential clinical candidate for AD.

Keywords: Alzheimer's disease, Hybrid compounds, Drug design, Multitarget drugs, Emerging targets for AD, Dual AChE Inhibitors, Antioxidants, Nrf2-EpRE inducers.


Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy